Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice

Breast Cancer Research

Volumn 13, Issue 4, 2011, Pages

  Kim, Eun J ^a   Choi, Mi Ran ^a   Park, Heesook ^a   Kim, Minhee ^a   Hong, Ji E ^a   Lee, Jae Yong ^a   Chun, Hyang S ^b   Lee, Ki W ^c   Yoon Park, Jung H ^a  

^a Hallym University   (South Korea)

^b Korea Food Research Institute   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; COLONY STIMULATING FACTOR 1; COMPLEMENT COMPONENT C5A; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; KI 67 ANTIGEN; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UROKINASE; VASCULAR CELL ADHESION MOLECULE 1; CCND1 PROTEIN, MOUSE; CD68 PROTEIN, MOUSE; CDK2 PROTEIN, MOUSE; CYTOKINE; DIFFERENTIATION ANTIGEN; INTERLEUKIN 16; LEUKOCYTE ANTIGEN; PTPRC PROTEIN, MOUSE;

ADIPOSE TISSUE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BODY WEIGHT; BREAST CARCINOMA; CALORIC INTAKE; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CANCER TISSUE; CARCINOMA CELL; CELL ADHESION; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT INTAKE; FEMALE; GONAD; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LIPID DIET; LIVER METASTASIS; LUNG METASTASIS; MACROPHAGE MIGRATION; METASTASIS; MOUSE; NONHUMAN; OBESITY; ORGAN WEIGHT; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SOLID TUMOR; SPLEEN; SURVIVAL RATE; TUMOR VOLUME; WESTERN BLOTTING; ANIMAL; CELL MOTION; DRUG EFFECT; EXPERIMENTAL NEOPLASM; LIVER TUMOR; LUNG; LUNG TUMOR; METABOLISM; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BODY WEIGHT; CELL MOVEMENT; CELL PROLIFERATION; COMPLEMENT C5A; CYCLIN A; CYCLIN D1; CYCLIN-DEPENDENT KINASE 2; CYTOKINES; DIETARY FATS; ENERGY INTAKE; FEMALE; INTERLEUKIN-16; KI-67 ANTIGEN; LEPTIN; LIVER NEOPLASMS; LUNG; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; OBESITY;

EID: 80051504968     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2927     Document Type: Article

References (46)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
2. Helman S, Harris JR. Diseases of Breast 2000, Philadelphia: Lippincott Williams & Wilkins.
3. Ali SM, Harvey HA, Lipton A. Metastatic breast cancer: overview of treatment. Clin Orthop Relat Res 2003, 415(Suppl):S132-S137.
4. Thiebaut AC, Kipnis V, Chang SC, Subar AF, Thompson FE, Rosenberg PS, Hollenbeck AR, Leitzmann M, Schatzkin A. Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst 2007, 99:451-462. 10.1093/jnci/djk094, 17374835.
5. Buettner R, Scholmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring, Md) 2007, 15:798-808.
6. Lin S, Thomas TC, Storlien LH, Huang XF. Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int J Obes Relat Metab Disord 2000, 24:639-646. 10.1038/sj.ijo.0801209, 10849588.
7. Carmichael AR. Obesity and prognosis of breast cancer. Obes Rev 2006, 7:333-340. 10.1111/j.1467-789X.2006.00261.x, 17038127.
8. Li Z, Bowerman S, Heber D. Health ramifications of the obesity epidemic. Surg Clin North Am 2005, 85:681-701. 10.1016/j.suc.2005.04.006, 16061080.
9. Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA. Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev 2005, 14:2009-2014. 10.1158/1055-9965.EPI-05-0106, 16103453.
10. Dawood S, Broglio K, Gonzalez-Angulo AM, Kau SW, Islam R, Hortobagyi GN, Cristofanilli M. Prognostic value of body mass index in locally advanced breast cancer. Clin Cancer Res 2008, 14:1718-1725. 10.1158/1078-0432.CCR-07-1479, 18347172.
11. Rose DP, Connolly JM, Meschter CL. Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice. J Natl Cancer Inst 1991, 83:1491-1495. 10.1093/jnci/83.20.1491, 1920496.
12. Ford CE, Ekstrom EJ, Andersson T. Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells. Proc Natl Acad Sci USA 2009, 106:3919-3924. 10.1073/pnas.0809516106, 2656180, 19237581.
13. Banka CL, Lund CV, Nguyen MT, Pakchoian AJ, Mueller BM, Eliceiri BP. Estrogen induces lung metastasis through a host compartment-specific response. Cancer Res 2006, 66:3667-3672. 10.1158/0008-5472.CAN-05-4416, 16585192.
14. Pulaski BA, Ostrand-Rosenberg S. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res 1998, 58:1486-1493.
15. Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992, 52:1399-1405.
16. Heppner GH, Miller FR, Shekhar PM. Nontransgenic models of breast cancer. Breast Cancer Res 2000, 2:331-334. 10.1186/bcr77, 138654, 11250725.
17. Olson LK, Tan Y, Zhao Y, Aupperlee MD, Haslam SZ. Pubertal exposure to high fat diet causes mouse strain-dependent alterations in mammary gland development and estrogen responsiveness. Int J Obesity 2010, 34:1415-1426.
18. Toth LA. Defining the moribund condition as an experimental endpoint for animal research. ILAR J 2000, 41:72-79.
19. Sauter BV, Martinet O, Zhang WJ, Mandeli J, Woo SL. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Proc Natl Acad Sci USA 2000, 97:4802-4807. 10.1073/pnas.090065597, 18313, 10758166.
20. Kim EJ, Shin M, Park H, Hong JE, Shin HK, Kim J, Kwon DY, Park JH. Oral administration of 3,3'-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. J Nutr 2009, 139:2373-2379. 10.3945/jn.109.111864, 19864400.
21. Welch DR, Neri A, Nicolson GL. Comparison of 'spontaneous' and 'experimental' metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Invasion Metastasis 1983, 3:65-80.
22. Rose DP, Connolly JM. Influence of dietary fat intake on local recurrence and progression of metastases arising from MDA-MB-435 human breast cancer cells in nude mice after excision of the primary tumor. Nutr Cancer 1992, 18:113-122. 10.1080/01635589209514211, 1437649.
23. Kim EJ, Hong JE, Eom SJ, Lee JY, Park JH. Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. Breast Cancer Res Treat 2011,
24. Cho HJ, Kim WK, Kim EJ, Jung KC, Park S, Lee HS, Tyner AL, Park JH. Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. Am J Physiol Gastrointest Liver Physiol 2003, 284:G996-G1005.
25. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival: modifications of the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986, 89:271-277. 10.1016/0022-1759(86)90368-6, 3486233.
26. Kwon GT, Cho HJ, Chung WY, Park KK, Moon A, Park JH. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. J Nutr Biochem 2009, 20:663-676. 10.1016/j.jnutbio.2008.06.005, 18824345.
27. Karnoub AE, Weinberg RA. Chemokine networks and breast cancer metastasis. Breast Dis 2006, 26:75-85.
28. McEligot AJ, Largent J, Ziogas A, Peel D, Anton-Culver H. Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutr Cancer 2006, 55:132-140. 10.1207/s15327914nc5502_3, 17044767.
29. Thomson CA, Thompson PA. Dietary patterns, risk and prognosis of breast cancer. Future Oncol 2009, 5:1257-1269. 10.2217/fon.09.86, 19852740.
30. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830. 296998, 14679177.
31. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808. 296995, 14679176.
32. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432. 10.1038/372425a0, 7984236.
33. McGregor GP, Desaga JF, Ehlenz K, Fischer A, Heese F, Hegele A, Lammer C, Peiser C, Lang RE. Radiommunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology 1996, 137:1501-1504. 10.1210/en.137.4.1501, 8625930.
34. Sinha MK, Opentanova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J, Becker GW, Bowsher RR, Stephens TW, Caro JF. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996, 98:1277-1282. 10.1172/JCI118913, 507552, 8823291.
35. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S, Surmacz E. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 2006, 12:1447-1453. 10.1158/1078-0432.CCR-05-1913, 16533767.
36. Hu X, Juneja SC, Maihle NJ, Cleary MP. Leptin: a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 2002, 94:1704-1711.
37. Cleary MP, Phillips FC, Getzin SC, Jacobson TL, Jacobson MK, Christensen TA, Juneja SC, Grande JP, Maihle NJ. Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors. Breast Cancer Res Treat 2003, 77:205-215. 10.1023/A:1021891825399, 12602920.
38. Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 2007, 7:139-147.
39. Albini A, Tosetti F, Benelli R, Noonan DM. Tumor inflammatory angiogenesis and its chemoprevention. Cancer Res 2005, 65:10637-10641. 10.1158/0008-5472.CAN-05-3473, 16322203.
40. Lewis CE, Leek R, Harris A, McGee JO. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 1995, 57:747-751.
41. Manabe Y, Toda S, Miyazaki K, Sugihara H. Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol 2003, 201:221-228. 10.1002/path.1430, 14517839.
42. Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti M, Pestell RG, Scherer PE. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 2003, 22:6408-6423. 10.1038/sj.onc.1206737, 14508521.
43. Walsh C, Tanjoni I, Uryu S, Tomar A, Nam JO, Luo H, Phillips A, Patel N, Kwok C, McMahon G, Stupack DG, Schlaepfer DD. Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models. Cancer Biol Ther 2010, 9:778-790. 10.4161/cbt.9.10.11433, 2933309, 20234193.
44. DuPre SA, Hunter KW. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. Exp Mol Pathol 2007, 82:12-24. 10.1016/j.yexmp.2006.06.007, 16919266.
45. Younos I, Donkor M, Hoke T, Dafferner A, Samson H, Westphal S, Talmadge J. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells. Int Immunopharmacol 2011, 11:816-826. 10.1016/j.intimp.2011.02.021, 21376153.
46. Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 2008, 8:228. 10.1186/1471-2407-8-228, 2529338, 18691423.